Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.

Mas-Oliva J, Navarro-Vidal E, Tapia-Vieyra JV.

PLoS One. 2014 Jan 22;9(1):e86089. doi: 10.1371/journal.pone.0086089. eCollection 2014.

PMID:
24465888
[PubMed - in process]
Free PMC Article
2.

The molecular basis for ethnic variation and histological subtype differences in prostate cancer.

Zong Y, Goldstein AS, Huang J.

Sci China Life Sci. 2013 Sep;56(9):780-7. doi: 10.1007/s11427-013-4522-0. Epub 2013 Jul 13. Review.

PMID:
23852643
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.

Terry S, Maillé P, Baaddi H, Kheuang L, Soyeux P, Nicolaiew N, Ceraline J, Firlej V, Beltran H, Allory Y, de la Taille A, Vacherot F.

Neoplasia. 2013 Jul;15(7):761-72.

PMID:
23814488
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.

Yan L, Xing Z, Guo Z, Fang Z, Jiao W, Guo X, Xu Z, Fang Z, Holmberg A, Nilsson S, Liu Z.

PLoS One. 2013;8(2):e55790. doi: 10.1371/journal.pone.0055790. Epub 2013 Feb 7.

PMID:
23409045
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.

Mosquera JM, Beltran H, Park K, MacDonald TY, Robinson BD, Tagawa ST, Perner S, Bismar TA, Erbersdobler A, Dhir R, Nelson JB, Nanus DM, Rubin MA.

Neoplasia. 2013 Jan;15(1):1-10.

PMID:
23358695
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells.

Liu T, Wu LY, Fulton MD, Johnson JM, Berkman CE.

Int J Oncol. 2012 Dec;41(6):2087-92. doi: 10.3892/ijo.2012.1649. Epub 2012 Oct 4.

PMID:
23041906
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.

Lescarbeau RM, Seib FP, Prewitz M, Werner C, Kaplan DL.

PLoS One. 2012;7(8):e40372. doi: 10.1371/journal.pone.0040372. Epub 2012 Aug 1.

PMID:
22870197
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prostate cancer with neuroendocrine differentiation--case report.

Glück G, Mihai M, Stoica R, Andrei R, Sinescu I.

J Med Life. 2012 Feb 22;5(1):101-4. Epub 2012 Mar 5.

PMID:
22574096
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells.

Delk NA, Farach-Carson MC.

Autophagy. 2012 Apr;8(4):650-63. doi: 10.4161/auto.19226. Epub 2012 Apr 1.

PMID:
22441019
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients.

Deng X, Elzey BD, Poulson JM, Morrison WB, Ko SC, Hahn NM, Ratliff TL, Hu CD.

Am J Cancer Res. 2011;1(7):834-44. Epub 2011 Aug 18.

PMID:
22016831
[PubMed]
Free PMC Article
11.

The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.

Hong SK, Kim JH, Lin MF, Park JI.

Exp Cell Res. 2011 Nov 1;317(18):2671-82. doi: 10.1016/j.yexcr.2011.08.008. Epub 2011 Aug 16.

PMID:
21871886
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2.

Pernicová Z, Slabáková E, Kharaishvili G, Bouchal J, Král M, Kunická Z, Machala M, Kozubík A, Souček K.

Neoplasia. 2011 Jun;13(6):526-36.

PMID:
21677876
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.

Qi J, Pellecchia M, Ronai ZA.

Oncotarget. 2010 Sep;1(5):379-85. Review.

PMID:
21037926
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.

Qi J, Nakayama K, Cardiff RD, Borowsky AD, Kaul K, Williams R, Krajewski S, Mercola D, Carpenter PM, Bowtell D, Ronai ZA.

Cancer Cell. 2010 Jul 13;18(1):23-38. doi: 10.1016/j.ccr.2010.05.024.

PMID:
20609350
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells.

McKeithen D, Graham T, Chung LW, Odero-Marah V.

Prostate. 2010 Jun 15;70(9):982-92. doi: 10.1002/pros.21132.

PMID:
20166136
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Molecular mechanisms of castration-resistant prostate cancer progression.

Dutt SS, Gao AC.

Future Oncol. 2009 Nov;5(9):1403-13. doi: 10.2217/fon.09.117. Review.

PMID:
19903068
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.

DaSilva J, Gioeli D, Weber MJ, Parsons SJ.

Cancer Res. 2009 Sep 15;69(18):7402-11. doi: 10.1158/0008-5472.CAN-08-4687. Epub 2009 Aug 25. Erratum in: Cancer Res. 2009 Oct 1;69(19):7894.

PMID:
19706771
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.

Yu SQ, Lai KP, Xia SJ, Chang HC, Chang C, Yeh S.

Asian J Androl. 2009 Jan;11(1):39-48. doi: 10.1038/aja.2008.44. Epub 2008 Dec 22. Review.

PMID:
19098932
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.

Sotomayor P, Godoy A, Smith GJ, Huss WJ.

Prostate. 2009 Mar 1;69(4):401-10. doi: 10.1002/pros.20895.

PMID:
19058139
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.

Deng X, Liu H, Huang J, Cheng L, Keller ET, Parsons SJ, Hu CD.

Cancer Res. 2008 Dec 1;68(23):9663-70. doi: 10.1158/0008-5472.CAN-08-2229.

PMID:
19047143
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk